Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maaike Y. Kapteijn"'
Autor:
Maaike Y. Kapteijn, Monika Yanovska, El Houari Laghmani, Rudmer J. Postma, Vincent van Duinen, Betül Ünlü, Karla Queiroz, Anton Jan van Zonneveld, Henri H. Versteeg, Araci M.R. Rondon
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 5, Pp 102475- (2024)
Background: Cancer increases the risk of venous thromboembolism, and glioblastoma is one of the cancer types with the highest risk of venous thromboembolism (10%-30%). Tumor-intrinsic features are believed to affect vascular permeability and hypercoa
Externí odkaz:
https://doaj.org/article/97a8c772b0a14681b54af697776277b4
Autor:
Chantal Kroone, Chris Tieken, Begüm Kocatürk, Madelon Paauwe, Erik J. Blok, Betül Ünlü, Yascha W. van den Berg, Eliana Stanganello, Maaike Y. Kapteijn, Nathalie Swier, Xi Zhang, Danique E. M. Duits, Yazhi Lin, Lisa V. E. Oostenbrink, Rob F. P. van den Akker, Laurent O. Mosnier, Lukas J. Hawinkels, Bart J. M. van Vlijmen, Wolfram Ruf, Peter J. Kuppen, Suzanne C. Cannegieter, Jeroen T. Buijs, Henri H. Versteeg
Publikováno v:
Blood Advances. 7:2388-2400
Cancer enhances the risk of venous thromboembolism, but a hypercoagulant microenvironment also promotes cancer progression. Although anticoagulants have been suggested as a potential anticancer treatment, clinical studies on the effect of such modali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a4eb516cd0223c73ab1a53b6f13214a
https://doi.org/10.1182/bloodadvances.2022008455
https://doi.org/10.1182/bloodadvances.2022008455
Autor:
Fleur H.J. Kaptein, Milou A.M. Stals, Maaike Y. Kapteijn, Suzanne C. Cannegieter, Linda Dirven, Sjoerd G. van Duinen, Ronald van Eijk, Menno V. Huisman, Eva E. Klaase, Martin J.B. Taphoorn, Henri H. Versteeg, Jeroen T. Buijs, Johan A.F. Koekkoek, Frederikus A. Klok
Publikováno v:
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. WILEY
Journal of Thrombosis and Haemostasis, 20(7), 1665-1673. WILEY
Background: Glioblastoma patients are considered to be at high risk of venous thromboembolism (VTE) and major bleeding (MB), although reliable incidence estimates are lacking. Moreover, the risk of arterial thromboembolism (ATE) in these patients is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec3266c3c3b3efd3c0167b2cf364e86
http://www.scopus.com/inward/record.url?scp=85129619655&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85129619655&partnerID=8YFLogxK
Autor:
Maaike Y. Kapteijn, Shanna Zwaan, Esther ter Linden, El Houari Laghmani, Rob F. P. van den Akker, Araci M. R. Rondon, Sabina Y. van der Zanden, Jacques Neefjes, Henri H. Versteeg, Jeroen T. Buijs
Publikováno v:
Cancers; Volume 15; Issue 8; Pages: 2347
Glioblastoma (GBM) patients have one of the highest risks of venous thromboembolism (VTE), which is even further increased upon treatment with chemotherapy. Tissue factor (TF) is the initiator of the extrinsic coagulation pathway and expressed by GBM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::340f102e0621cc77a1d0fecf027fbad6
Autor:
Maaike Y. Kapteijn, Fleur H.J. Kaptein, Milou A.M. Stals, Eva E. Klaase, Inés García-Ortiz, Ronald van Eijk, Dina Ruano, Sjoerd G. van Duinen, Suzanne C. Cannegieter, Martin J.B. Taphoorn, Linda Dirven, Johan A.F. Koekkoek, Frederikus A. Klok, Henri H. Versteeg, Jeroen T. Buijs
Publikováno v:
Thrombosis Research, 221, 10-18. Elsevier Limited
Background and objectives: Patients with glioblastoma have a high risk of developing venous thromboembolism (VTE). However, the role of underlying genetic risk factors remains largely unknown. Therefore, the aim of this study was to discover whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c950906d47dbc08bdaf2f4d88ef897
https://research.vumc.nl/en/publications/c4d90e6b-c900-4cde-ae9a-94d50ad12049
https://research.vumc.nl/en/publications/c4d90e6b-c900-4cde-ae9a-94d50ad12049
Autor:
Linda Dirven, F.A. Klok, M A M Stals, J A F Koekoek, S. G. Van Duinen, Maaike Y. Kapteijn, Jeroen T. Buijs, F H J Kaptein, Martin J B Taphoorn, Henri H. Versteeg
Publikováno v:
Neuro-Oncology. 23:ii20-ii21
BACKGROUND Patients with glioblastoma have a high risk of developing venous thromboembolism (VTE). However, the underlying genetic risk factors remain largely unknown. Therefore, the aim of our study was to discover whether genetic aberrations in gli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b978d94646d50754d5c0f9d8ab04bb6
https://doi.org/10.1093/neuonc/noab180.067
https://doi.org/10.1093/neuonc/noab180.067
Autor:
Tyler E. Miller, Analisa DiFeo, Ian Bayles, Gursimran Dhillon, Stevephen Hung, Frederick Allen, Cynthia F. Bartels, Alberto Righi, Maaike Y. Kapteijn, Brian P. Rubin, Alex Yee-Chen Huang, Peter C. Scacheri, Arnulfo Mendoza, Michael M. Lizardo, Paul S. Meltzer, James J. Morrow, Lee J. Helman, John A. Stamatoyannopoulos, Daniel R. Chee, Alister P. W. Funnell, Piero Picci, Jay Myers, Alina Saiakhova, Henri H. Versteeg, Chand Khanna, Marco Gambarotti
Publikováno v:
Nature medicine
Nature Medicine, 24(2), 176
Nature Medicine, 24(2), 176
Metastasis results from a complex set of traits acquired by tumor cells, distinct from those necessary for tumorigenesis. Here, we investigate the contribution of enhancer elements to the metastatic phenotype of osteosarcoma. Through epigenomic profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c22baf9ef834db1602c9c30816b710f0
https://doi.org/10.1038/nm.4475
https://doi.org/10.1038/nm.4475
Autor:
M V Huisman, M A M Stals, Johan A F Koekkoek, F H J Kaptein, Martin J B Taphoorn, E Klaase, Suzanne C. Cannegieter, Linda Dirven, Maaike Y. Kapteijn, F.A. Klok
Publikováno v:
Neuro Oncol
BACKGROUND Patients with glioblastoma are considered to be at high risk of venous thromboembolism (VTE) and major bleeding (MB), although reliable incidence estimates are lacking. The aim of this study was to assess the cumulative incidence, risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::069c416efda5911395e4916f3cc3034c
https://doi.org/10.1093/neuonc/noab180.130
https://doi.org/10.1093/neuonc/noab180.130
Publikováno v:
Seminars in Thrombosis and Hemostasis
Seminars in Thrombosis and Hemostasis, 45(4), 396-412. THIEME MEDICAL PUBL INC
Seminars in Thrombosis and Hemostasis, 45(4), 396-412. THIEME MEDICAL PUBL INC
It has been long-established that cancer and thrombosis are linked, but the exact underlying pathological mechanism remains to be unraveled. As the initiator of the coagulation cascade, the transmembrane glycoprotein tissue factor (TF) has been inten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61434be977de42fa8fa2826070f2b861
https://hdl.handle.net/1887/122476
https://hdl.handle.net/1887/122476
Autor:
Gursimran Dhillon, Stevephen Hung, Cynthia F. Bartels, Frederick Allen, Peter C. Scacheri, Brian P. Rubin, Daniel R. Chee, Ian Bayles, James J. Morrow, Alberto Righi, Arnulfo Mendoza, Jay Myers, John A. Stamatoyannopoulos, Marco Gambarotti, Chand Khanna, Tyler E. Miller, Analisa DiFeo, Maaike Y. Kapteijn, Alister P. W. Funnell, Alex Yee-Chen Huang, Piero Picci, Michael M. Lizardo, Paul S. Meltzer, Alina Saiakhova, Lee J. Helman, Henri H. Versteeg
Publikováno v:
Nature Medicine. 24:525-525
Nat. Med. 24, 176–185 (2018); published online 15 January 2018; corrected after print 7 February 2018 In the version of this article initially published, two of the authors are incorrectly identified as John Stamatoyannopolus and Henri Versteeg. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::737d636b401567f79baf7c6e793b1c11
https://doi.org/10.1038/nm0418-525c
https://doi.org/10.1038/nm0418-525c